DeepMed Research

MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Managing Pain in Patients With MTP Arthritis

Not Applicable

Completed

Conditions: Hallux Rigidus

Interventions: Device: Morton's extension insoles
Device: Vktory insoles

First Posted Date: 2021-04-06

Last Posted Date: 2021-04-06

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 14

Registration Number: NCT04833608

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Newton Wellesley Hospital, Newton, Massachusetts, United States

Neuromodulation of Mind-Wandering in Depression

Not Applicable

Active, not recruiting

Conditions: Depression

Interventions: Device: BrainSonix Pulsar 1002

First Posted Date: 2021-04-06

Last Posted Date: 2024-01-23

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 80

Registration Number: NCT04832685

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

List Experiment to Measure Food and Water Insecurity

Not Applicable

Conditions: Food Deprivation
Water Deprivation

Interventions: Other: Survey questionnaire

First Posted Date: 2021-04-05

Last Posted Date: 2021-04-05

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 1553

Registration Number: NCT04832243

Locations: 🇺🇬
Mbarara University of Science and Technology, Mbarara, Uganda

Measuring Beliefs and Norms About Persons With Alcohol Use Disorder

Not Applicable

Completed

Conditions: Alcohol Use Disorder (AUD)

Interventions: Other: Survey questionnaire

First Posted Date: 2021-04-05

Last Posted Date: 2023-10-19

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 1363

Registration Number: NCT04832321

Locations: 🇺🇬
Mbarara University of Science and Technology, Mbarara, Uganda

Promoting Well-being and Health in Heart Failure

Not Applicable

Recruiting

Conditions: Heart Failure NYHA Class I
Heart Failure
Heart Failure NYHA Class II
Heart Failure NYHA Class III

Interventions: Behavioral: PP-MI Intervention
Behavioral: MI-alone Intervention

First Posted Date: 2021-04-02

Last Posted Date: 2025-04-04

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 280

Registration Number: NCT04829617

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Noninvasive Biomarkers of Metabolic Liver Disease 1.1

Not Applicable

Completed

Conditions: Nonalcoholic Steatohepatitis
Nonalcoholic Fatty Liver

Interventions: Device: Ultrasound based shear wave speed and fat quantification methods
Diagnostic Test: Blood collection
Other: Physical measurements
Other: Clinical history and medication reviews

First Posted Date: 2021-04-02

Last Posted Date: 2023-07-11

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 40

Registration Number: NCT04828551

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
UC San Diego, San Diego, California, United States

Covid-19 Vaccine Responsiveness in MM and Waldenstrom

Conditions: Immune System Disorder
Covid19
Multiple Myeloma
Waldenstrom Macroglobulinemia

First Posted Date: 2021-04-02

Last Posted Date: 2021-04-02

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 160

Registration Number: NCT04830046

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States

The Role of Wearable Devices in Cardiothoracic Surgery: Predicting and Detecting Early Postoperative Complications

Recruiting

Conditions: Surgery--Complications

First Posted Date: 2021-04-01

Last Posted Date: 2024-11-19

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 1200

Registration Number: NCT04824066

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Telaglenastat + Talazoparib In Prostate Cancer

Phase 2

Conditions: Prostate Cancer Metastatic

Interventions: Drug: Telaglenastat
Drug: Talazoparib

First Posted Date: 2021-04-01

Last Posted Date: 2021-04-01

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 30

Registration Number: NCT04824937

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Evaluation of Medical Cannabis and Prescription Opioid Taper Support for Reduction of Pain and Opioid Dose in Patients With Chronic Non-Cancer Pain

Not Applicable

Active, not recruiting

Conditions: Opioid Use
Marijuana Use
Pain

Interventions: Drug: Medical Marijuana
Behavioral: Prescription Opioid Taper Support (POTS)

First Posted Date: 2021-04-01

Last Posted Date: 2025-05-16

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 87

Registration Number: NCT04827992

Locations: 🇺🇸
Maine Medical Center, Portland, Maine, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Cambridge Health Alliance, Cambridge, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy